Emergent Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Emergent Biosolutions' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Emergent Biosolutions in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
5.2811.4117.54
Details
Intrinsic
Valuation
LowReal ValueHigh
10.9724.6530.78
Details
6 Analysts
Consensus
LowTarget PriceHigh
50.0062.5075.00
Details
Earnings
Estimates (4)
LowProjected EPSHigh
4.695.416.28
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Emergent Biosolutions. Your research has to be compared to or analyzed against Emergent Biosolutions' peers to derive any actionable benefits. When done correctly, Emergent Biosolutions' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Emergent Biosolutions.

Emergent Biosolutions Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Emergent Biosolutions and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Emergent and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Emergent Biosolutions does not affect the price movement of the other competitor.

Related Correlations

MRK
JNJ
XTWO
FENY
MRK
0.950.040.84
MRK
JNJ
0.950.170.76
JNJ
XTWO
0.040.17-0.02
XTWO
FENY
0.840.76-0.02
FENY
MRK
JNJ
XTWO
FENY
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

Nowadays, there is a big difference between Emergent Stock performing well and Emergent Biosolutions company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Emergent Biosolutions' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Compare Emergent Biosolutions and related stocks such as Merck Company, Johnson Johnson, Bondbloxx ETF Trust, and Fidelity MSCI Energy Net Income Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
MRK861 M6.3 B6.2 B4.4 B11.9 B4.4 B3.9 B2.4 B6.2 B9.8 B7.1 B13 B14.1 B
JNJ9.7 B9.7 B16.5 B16.5 B16.5 B16.5 B16.5 B1.3 B20.9 B20.9 B20.9 B20.9 B11.7 B

Emergent Biosolutions and related stocks such as Merck Company, Johnson Johnson, Bondbloxx ETF Trust, and Fidelity MSCI Energy Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Emergent Biosolutions financial statement analysis. It represents the amount of money remaining after all of Emergent Biosolutions operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Emergent Biosolutions Competitive Analysis

The better you understand Emergent Biosolutions competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Emergent Biosolutions' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Emergent Biosolutions' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
EBSMRKJNJXTWOFENY
 3.25 
 12.38 
Emergent
 1.06 
 110.09 
Merck
 0.61 
 177.17 
Johnson
 0.22 
 49.62 
Bondbloxx
 0.34 
 23.25 
Fidelity
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
One Year Return
Beta
Price to Book
Equity Positions Weight
Shares Outstanding
Three Year Return
Annual Yield
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Target Price
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Emergent Biosolutions Competition Performance Charts

Complement your Emergent Biosolutions position

In addition to having Emergent Biosolutions in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Insurance Providers Thematic Idea Now

Insurance Providers
Insurance Providers Theme
Companies providing all types of insurance and insurance services. The Insurance Providers theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Providers Theme or any other thematic opportunities.
View All  Next Launch
Continue to Emergent Biosolutions Correlation with its peers. Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Emergent Stock analysis

When running Emergent Biosolutions price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.022
Market Capitalization
608.1 M
Quarterly Revenue Growth YOY
(0.27) 
Return On Assets
0.0464
Return On Equity
0.036
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine Emergent Biosolutions value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
EBS
 Stock
  

USD 12.38  0.39  3.25%   

Emergent Biosolutions competes with Merck, Johnson Johnson, Bondbloxx ETF, and Fidelity MSCI; as well as few others. The company runs under Biotechnology sector within Health Care industry. Analyzing Emergent Biosolutions competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Emergent Biosolutions to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Emergent Biosolutions competition on your existing holdings. Continue to Emergent Biosolutions Correlation with its peers.
  
As of 12/07/2022, Return on Sales is likely to grow to 0.21, while Return on Investment is likely to drop 12.52. Emergent Biosolutions Total Assets are relatively stable at the moment as compared to the past year. Emergent Biosolutions reported last year Total Assets of 2.96 Billion. As of 12/07/2022, Current Assets is likely to grow to about 1.4 B, while Goodwill and Intangible Assets are likely to drop slightly above 660.3 M.